Media Summary: Moderator John L. Marshall, MD, introduces a panel discussion focused on the treatments available in the second- and later-line ... Dr. Howard Hochster from the Yale Cancer Center in New Haven discusses the importance of genetic In this segment, panelists discuss the necessity of
Introduction Expanded Ras Mutation Testing - Detailed Analysis & Overview
Moderator John L. Marshall, MD, introduces a panel discussion focused on the treatments available in the second- and later-line ... Dr. Howard Hochster from the Yale Cancer Center in New Haven discusses the importance of genetic In this segment, panelists discuss the necessity of For more resources and information regarding anticancer targeted therapies: Colorectal cancer is the second most common cancer worldwide. 51% of all metastatic colorectal cancers are driven by Dr. Michael Via presented the article entitled, "Utilities of
Panelists discuss the phase III PRIME study and the phase II PEAK study, two recent biomarker analyses that focused on the role ... Marc Peeters, MD, PhD, department of oncology, Antwerp University Hospital, Antwerpen, Belgium, discusses an Like and Share the video if you find it useful. Do not forget to Subscribe to our channel to receive more updates. Subscribe ... The panelists, Charles S. Fuchs, MD, MPH; Richard Kim, MD; and Daniel G. Haller, MD, FACP, FRCP, explain
